Navigation Links
ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
Date:7/29/2008

ATHENS, Ga., July 29 /PRNewswire/ -- ArunA Biomedical, Inc., the first company to commercialize human embryonic stem cell derived products and services, announced today that William T. Sharp has been named President and Chief Executive Officer. In addition to his ArunA leadership responsibilities, Mr. Sharp has also been appointed to ArunA's Board of Directors. Mr. Sharp succeeds ArunA founder Steven Stice, PhD, who will remain ArunA's Chairman and Chief Scientific Officer. Dr. Stice remarked, "We are pleased to welcome Bill to ArunA. Bill has an extensive background leading life science businesses and his leadership is critical to the success of the company's next phase of growth. Bill's experience and expertise in the industry are key elements to further positioning ArunA as the industry leader in this emerging market."

Mr. Sharp brings more that twenty-five years of industry leadership experience to ArunA Biomedical. His experience spans Fortune 500 to emerging and mid-sized businesses in the life science tools, diagnostics and clinical markets and Mr. Sharp has played major roles in mergers and acquisitions of several companies. Most recently, Mr. Sharp served as Chief Commercial Officer of BioProcessors Corporation, a venture-financed life science tools developer based in the Boston area, where he led global commercialization efforts of the company's proprietary high-throughput mammalian cell culture technology. Prior to BioProcessors, Mr. Sharp was Senior VP of Business Development with Cellomics (acquired by Fisher), Vice President of Business Development with Gentra Systems (now Qiagen), Worldwide Director for the Molecular Biology Business of Life Technologies (now Invitrogen), and Vice President of Sales and Marketing with Heraeus Instruments. Mr. Sharp holds MS and BA degrees from The Pennsylvania State University.

"Steve Stice and ArunA's outstanding team of scientists are dedicated to discovering and developing tools that will ultimately create opportunities to improve the quality of life for millions of people suffering from devastating diseases," stated Mr. Sharp. "ArunA's first commercial product, ENSTem-A(TM), is based on a proprietary technology licensed from the University of Georgia and is commercially available through a distribution relationship with Millipore Corporation. This product, along with several others in ArunA's near-term development pipeline, should help to accelerate the pace of research for scientists around the world. I am thrilled to be associated with a company on the leading edge of such a promising field. I look forward to leading ArunA as we proceed down a path of continuous and rapid development of enabling new products and services that will serve as a catalyst leading to the discovery of novel therapeutic compounds, tests for neurotoxicity and breakthroughs in understanding human development and diseases."

About ArunA Biomedical

Located in Athens, Georgia, ArunA Biomedical, Inc. is a privately held biotechnology corporation dedicated to the discovery, manufacturing and commercialization of emerging new technologies in human embryonic stem cell research for use in drug discovery and basic research. ArunA is the first company to commercialize products derived from human embryonic stem cells and sees its proprietary technology as a catalyst leading to the discovery of novel therapeutic compounds, tests for neurotoxicity and breakthroughs in understanding human development and diseases. The company's first product, ENSTem-A(TM), was introduced through a distribution relationship with Millipore in 2007 and is based on proprietary technology licensed from the University of Georgia. ArunA also provides comprehensive testing and assay services based on their expertise and unique human stem cell derived research tools. For more information, visit http://www.arunabiomedical.com.


'/>"/>
SOURCE ArunA Biomedical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
2. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
3. Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test
4. SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market
5. NCIIA Announces Launch of 4th Annual Student Biomedical Innovation Competition
6. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
7. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
8. Crux Biomedical Announces First Successful U.S. Implant of Its New Retrievable Inferior Vena Cava (IVC) Filter
9. Environmental Tectonics Corporations BioMedical Division Announces New Contract
10. Avery Biomedical Devices, Inc. Appoints Elefteriades to its Board of Directors
11. Verax Biomedical Receives ISO Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... May 22, 2017 , ... Cancer diagnostics and pathology ... B2 at the Association for Pathology Informatics Annual Summit at the ... demonstrating its Cancer Diagnostic Cockpit and Consultation Portal, Inspirata will present research it ...
(Date:5/21/2017)... ... 20, 2017 , ... CNSDose is a genetically driven, clinically ... by finding the right antidepressant faster. CNSDose speeds recovery and reduces side ... personalized approach to treatment. , A peer-reviewed and published, 12-week double-blind ...
(Date:5/19/2017)... ... 19, 2017 , ... The University City Science Center is ... for commercialization, and who are affiliated with the 21 partner academic and research ... now in its tenth round, is the first multi-institutional proof-of-concept program for the ...
(Date:5/18/2017)... San Diego, California (PRWEB) , ... May 18, ... ... looking for team-building activities. The Tapas Cooking Challenge is a two-hour team-building ... from a delicious menu created by Chef Jodi Abel, which include items, such ...
Breaking Biology Technology:
(Date:4/18/2017)... April 18, 2017  Socionext Inc., a global expert in SoC-based ... edge server, the M820, which features the company,s hybrid codec technology. ... by Tera Probe, Inc., will be showcased during the upcoming Medtec ... show at the Las Vegas Convention Center ... Click here ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... grow at a CAGR of 30.37% during the period 2017-2021. ... prepared based on an in-depth market analysis with inputs from industry ... over the coming years. The report also includes a discussion of ...
(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
Breaking Biology News(10 mins):